Junjiao Ping
Biographic Data
| ID | 7954474 |
|---|---|
| NAME | Junjiao Ping |
| GIVEN NAMES | Junjiao |
| FAMILY NAME | Ping |
| SIGNATURE | PING J |
| AFFILIATIONS | Zhongshan People's Hospital |
| ORCID | 0009-0001-6454-9444 |
| VERIFIED | Yes |
| TOTAL WORKS | 4 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 4 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2021 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
BDNF genetic variants modulate the impact of childhood trauma on symptom dimensions in first-episode schizophrenia
These findings demonstrate that BDNF polymorphisms act as genetic modifiers of trauma-related symptom expression, supporting a gene-environment interaction model underlying phenotypic heterogeneity in schizophrenia
The role of cognitive function in predicting metabolic risk in schizophrenia
Modeling based on concise clinical and cognitive indicators can effectively achieve metabolic risk stratification in patients with schizophrenia. Rather than relying on a single algorithm, combining the complementary strengths of RF and SVM and selecting models according to specific clinical needs and data characteristics may improve the identification of high-risk individuals and support proactive intervention and management
Trends in incidence, prevalence, and disability-adjusted life years of schizophrenia in China from 1990 to 2021, with projections for 2022-2050
GBD 2021 data reveal a rising SCZ burden in China, especially in ASPR and ASDR, posing increasing public health challenges. Males bore a consistently higher burden, but the female burden increased faster than the global average, highlighting gender-specific concerns. Age patterns emphasize young and middle-aged populations as key targets for intervention. Projected increases in incidence and mortality call for enhanced, tailored prevention and tr…
Naloxone Alleviate the Severity of Delirium in Hospitalized Patients With Parkinsonism
Purpose: Delirium is common in geriatric with Parkinson's disease (PD). Treatments for delirium have generally been neuroleptics; however, antipsychotics have potential effect to block striatal dopamine D2 receptors and worsen symptom of parkinsonism. We explored whether naloxone can alleviate delirium in PD and other forms of parkinsonism. Patients and Methods: Patients with parkinsonism who met the delirium criteria of the Diagnostic and Statis…
No prominent works on this page.
Naloxone Alleviate the Severity of Delirium in Hospitalized Patients With Parkinsonism
Purpose: Delirium is common in geriatric with Parkinson's disease (PD). Treatments for delirium have generally been neuroleptics; however, antipsychotics have potential effect to block striatal dopamine D2 receptors and worsen symptom of parkinsonism. We explored whether naloxone can alleviate delirium in PD and other forms of parkinsonism. Patients and Methods: Patients with parkinsonism who met the delirium criteria of the Diagnostic and Statis…
Trends in incidence, prevalence, and disability-adjusted life years of schizophrenia in China from 1990 to 2021, with projections for 2022-2050
GBD 2021 data reveal a rising SCZ burden in China, especially in ASPR and ASDR, posing increasing public health challenges. Males bore a consistently higher burden, but the female burden increased faster than the global average, highlighting gender-specific concerns. Age patterns emphasize young and middle-aged populations as key targets for intervention. Projected increases in incidence and mortality call for enhanced, tailored prevention and tr…
BDNF genetic variants modulate the impact of childhood trauma on symptom dimensions in first-episode schizophrenia
These findings demonstrate that BDNF polymorphisms act as genetic modifiers of trauma-related symptom expression, supporting a gene-environment interaction model underlying phenotypic heterogeneity in schizophrenia
The role of cognitive function in predicting metabolic risk in schizophrenia
Modeling based on concise clinical and cognitive indicators can effectively achieve metabolic risk stratification in patients with schizophrenia. Rather than relying on a single algorithm, combining the complementary strengths of RF and SVM and selecting models according to specific clinical needs and data characteristics may improve the identification of high-risk individuals and support proactive intervention and management
Medicine (2 works) · Psychiatry (2 works) · Psychology (2 works) · Schizophrenia (object-oriented programming (2 works) · Schizophrenia research and treatment (2 works) · Alcoholism and Thiamine Deficiency (1 works) · Anesthesia (1 works) · Anesthesia and Sedative Agents (1 works) · Brain-derived neurotrophic factor (1 works) · Child Abuse and Trauma (1 works)